| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.3M | +4.9% |
| Cost of Revenue | $16.1M | +11.1% |
| Gross Profit | -$4.8M | -29.1% |
| R&D Expense | $12.5M | +76.8% |
| SG&A Expense | $16.6M | -9.7% |
| Operating Income | -$33.9M | -14.2% |
| Pre-tax Income | -$33.8M | -6.6% |
| Income Tax | $0 | — |
| Net Income | -$33.8M | -6.6% |
| EPS (Basic) | -$4.00 | +63.5% |
| EPS (Diluted) | -$4.00 | +63.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.6M | +84.9% |
| Accounts Receivable | $2.1M | +23.7% |
| Inventory | $2.3M | +29.0% |
| Current Assets | $26.4M | +74.7% |
| Total Assets | $41.3M | +46.4% |
| Current Liabilities | $6.6M | -20.1% |
| Long-term Debt | $4.0M | +1.6% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.3M | -35.1% |
| Capital Expenditures | $654K | +1420.9% |
| Investing Cash Flow | -$2.5M | +20.6% |
| Financing Cash Flow | $42.2M | +22.4% |
| Free Cash Flow | -$31.0M | -37.8% |
| $13.5M |
| +8.8% |
| Stockholders' Equity | $27.8M | +75.9% |